Medical Research
(H80)
990 on File
DELAWARE DIABETES COALITION INC
Financial strength (30%)
60/100
Reliability (20%)
55/100
Effectiveness (25%)
61/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Financial Overview — FY 2025
$44K
Total Revenue
$38K
Total Expenses
$29K
Net Assets
N/A
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
99.3%
Fundraising Efficiency
85.8%
Operating Reserve
9.05x
Liability-to-Asset
N/A
Revenue Diversification
93.5%
Compared with Peers
FY 2025
Compared with 378 similar organizations
(United States, Medical Research, under $100K in expenses), FY 2025.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
99.3% | 75.9% |
P10P90
|
Top quarter |
|
Fundraising efficiency
Fundraising expenses / gross fundraising income
· lower is better
|
85.8% | 31.0% |
P10P90
|
Bottom quarter |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
9.1 mo | 44.2 mo |
P10P90
|
Below median |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
93.5% | 100.0% |
P10P90
|
Above median |
|
Revenue growth
Year over year revenue growth
|
4.6% | 2.1% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
0.1% | -2.5% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
12.5% | 20.0% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2025 | $44K | $38K | $29K | 99.3% | — |
| 2024 | $42K | $38K | $23K | 99.2% | — |
| 2023 | $49K | $45K | $20K | 99.4% | — |
| 2022 | $44K | $36K | $16K | 99.2% | — |
| 2021 | $44K | $42K | N/A | — | 1 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.